Seeing Is Believing

Currently out of the existing stock ratings of Richard Parkes, 3 are a BUY (50%), 2 are a HOLD (33.33%), 1 are a SELL (16.67%).
Analyst Richard Parkes, currently employed at BNP, carries an average stock price target met ratio of 100% that have a potential upside of 22.41% achieved within 306 days. Previously, Richard Parkes worked at DEUTSCHE BANK.
Richard Parkes’s has documented 10 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 02-Dec-2024.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/27/2022. The price target of $52.88 was fulfilled within 1 day with a profit of $0.48 (0.9%) receiving and performance score of 9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$105
$-83.41 (-44.27%)
$95
7 months ago
(09-Dec-2025)
0/13 (0%)
$-72.77 (-40.93%)
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
7 months 14 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
8 months 12 days ago
(27-Oct-2025)
4/4 (100%)
$13.48 (10.43%)
88
Buy Since 30-May-2024
$97
1 years 3 months 9 days ago
(30-Mar-2025)
0/2 (0%)
$-43.8 (-31.11%)
Hold Since 12-Feb-2025
1 years 4 months 27 days ago
(12-Feb-2025)
6/6 (100%)
$29.07 (22.44%)
674
What Year was the first public recommendation made by Richard Parkes?